Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trialLai Xu, Ziqiang Wang, Ming Zhong et al.|The Lancet Oncology|2021Cited by 184
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC TrialJunyang Lu, Ang Li, Jiadi Xing et al.|Journal of Clinical Oncology|2024Cited by 43
Transanal total mesorectal excision for rectal cancer: a multicentric cohort studyLiang Kang, Jianping Wang, Yuanguang Chen et al.|Gastroenterology report|2019Cited by 39
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trialYingchi Yang, Zhongtao Zhang, Guole Lin et al.|Nature Medicine|2025Cited by 30
Exploration of the Key Proteins in the Normal-Adenoma-Carcinoma Sequence of Colorectal Cancer Evolution Using In-Depth Quantitative ProteomicsYin Zhang, Yi Xiao|Journal of Oncology|2021Cited by 8